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Abstract: Combining the delivery
of multiple health interventions has
the potential to minimize costs and
expand intervention coverage. Inte-
gration of mass drug administration
is therefore being encouraged for
delivery of preventive chemothera-
py (PCT) to control onchocerciasis,
lymphatic filariasis, schistosomiasis,
soil-transmitted helminthiasis, and
trachoma in sub-Saharan Africa, as
there is considerable geographical
overlap of these neglected tropical
diseases (NTDs). With only a handful
of countries having embarked on
integrated NTD control, experience
on how to develop and implement
an efficient integrated programme
is limited. Historically, national and
global programmes were focused
on the control of only one disease,
usually through a comprehensive
approach that involved several in-
terventions including PCT. Over-
coming the resulting disease-specif-
ic structures and thinking, and
ensuring that the integrated pro-
gramme is embedded within the
existing health structures, pose con-
siderable challenges to policy mak-
ers and implementers wishing to
embark on integrated NTD control.
By sharing experiences from
Uganda, Tanzania, Southern Sudan,
and Mozambique, this symposium
article aims to outlines key challeng-
es and solutions to assist countries
in establishing efficient integrated
NTD programmes.
The Challenge
Resources for disease control are limited
and thus need to be used efficiently [1].
This need is particularly apparent for the
control of neglected tropical diseases
(NTDs), which, until recently, was largely
unfunded [2]. Integration of disease-
specific programmes is therefore being
encouraged for onchocerciasis, lymphatic
filariasis (LF), schistosomiasis, soil-trans-
mitted helminth (STH) infection, and
trachoma [3,4]. These NTDs occur over
more or less the same areas and their
control depends, although not exclusively,
on regular mass drug administration
(MDA) of safe and effective preventive
chemotherapy (PCT) [5]; combined PCT
delivery should thus minimize costs and
increase coverage [6,7]. However, ‘‘real
world’’ experience of implementing such
integrated NTD control is limited [8,9],
making it difficult to decide how best to
embark on, and proceed with, the devel-
opment of an integrated NTD control
programme in a manner that promotes
efficiency and local ownership—both pre-
requisites for sustainability.
Tutorial
What is integrated NTD control?
Integrated delivery of health services
covers a range of approaches and the
definition is therefore context dependent
[10–12]. Here we focus on a group of
NTDs for which regular MDA of PCT is
key to effective control, namely onchocer-
ciasis, LF, schistosomiasis, STH infection,
and trachoma. In this context, integration
is usually applied to creation of ‘‘PCT
packages’’ by combining MDA for more
than one NTD. Some countries have
formed umbrella NTD programmes to
oversee vertical delivery of these packages
through campaigns or other channels. In
other settings, a more ‘‘horizontal’’ ap-
proach is applied whereby intervention
packages are delivered as part of routine
health care and education programmes.
Both approaches provide opportunities for
‘‘integration’’ [13,14] and are by no means
mutually exclusive [15]. Instead they
should be coordinated and combined with
the goal of maximising efficiency [16].
What challenges should be
anticipated?
Integrating components of control strat-
egies for different diseases is technically
and managerially challenging. It is good to
appreciate these challenges at the outset,
so as to be able to manage expectation of
donors, programme managers, and bene-
ficiaries, as well as the roles and respon-
sibilities of a multitude of stakeholders.
Clear leadership of an integrated pro-
gramme will need to be established. In
countries with existing disease-specific
control programmes, this may mean
combining similar roles and responsibili-
ties of various programme managers
under one position, which could result in
redundancies. Alternatively, the pro-
gramme leadership may be assigned to
one individual while the other managers of
formerly disease-specific programmes con-
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the integrated approach. In any case, such
restructuring may cause resentment
among managers, in extreme cases leading
to obstruction and other difficulties in
managing the process. Another human
resource implication to be aware of is the
need for substantial training. Staff at all
levels will need to acquire new knowledge
about the additional diseases they are now
meant to control, and about the collection
and interpretation of data to monitor and
evaluate their integrated programmes.
What preparatory activities are
required?
Collection and collation of historical and
current information on NTDs will provide
essential background to launch the integra-
tion process (Figure 1). These data should be
gathered though: (i) searches of the pub-
lished and grey literature and analysis of
relevant health statistics, and (ii) a situation
analysis meeting by local experts. Available
d a t ac a nt h e nb eu s e dt od e v e l o pm a p s
showing the distribution of the targeted
diseases, highlighting areas of NTD overlap
where PCT delivery may be combined and
areas that remain to be surveyed. Collating
this information in a detailed situation
analysis(e.g.[17,18])willallowidentification
of gapsand potential meansto close them,as
well as provide a useful document to
advocate for implementation funds.
Where should integration be
started?
The country’s Ministry of Health
(MoH) needs to initiate integration by
deciding which departments and pro-
grammes should be part of the process.
A programme secretariat or equivalent
body may be formed to coordinate these,
consisting of the managers of the disease-
specific programmes and, where possible,
representatives of the Ministry of Educa-
tion and the water/sanitation sector. In
our experience, the key role of the
secretariat is to oversee programme im-
plementation, with the aim of maintaining
(or creating) a close link between NTD
control and the health, education, and
water/sanitation sector, hence preventing
establishment of vertical programmes.
What’s next?
Strong partnerships between stakehold-
ers from different sectors will be vital if the
newly formed programme is to succeed in
mobilizing resources, securing political
commitment, and applying the strengths
of the partners synergistically. A partner-
ship mechanism, such as a NTD working
group or task force, will therefore be
needed to enlist and coordinate the
required technical and implementation
support from all stakeholders (Figure 1).
To establish the partnership, the pro-
gramme secretariat should approach in-
country representatives of international
agencies, including the World Health
Organization (WHO), United Nations
Children’s Fund, World Food Programme
and the World Bank, relevant national and
international non-governmental organiza-
tions (NGOs), and key donors. In some
countries it may also be possible to enlist
the Water, Sanitation, and Hygiene
(WASH) partnership (see http://www.
wsscc.org) and/or pharmaceutical compa-
nies.
Clear terms of reference, broad partic-
ipation, and flexibility to accommodate
expansion will help the partnership to gain
momentum. In some countries, a national
stakeholder workshop has been held to
facilitate the integration process. The
value of such an event is greatly dependent
on timing; we have found it most useful to
convene a workshop to review a draft
strategic plan, rather than to initiate the
strategic planning process (Figure 1).
Developing a draft strategy for discus-
sion among NTD control partners is the
first technical task for the programme
secretariat. Strategic planning will require
identification of the integration goal, the
desired output(s) to be achieved within a
specific timeframe (usually 3–5 years), and
the associated objectives and activities
(Figure 2). A set of generic questions may
be useful for this purpose (Box 1). Though
formulation of the strategy should be led
by the programme secretariat, other
partners need to be encouraged to con-
tribute, particularly their experience on
what is feasible with existing resources and
knowledge.
What should be integrated and what
not?
At the outset, it may seem tempting to
merge all seemingly similar components of
the existing NTD programmes. Health
education or training materials, for exam-
ple, could easily be combined into versions
covering all of the targeted diseases. In our
Figure 2. Development of a programme framework. Modified from [47].
doi:10.1371/journal.pntd.0000755.g002
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cation messages rather than complicated
instructions tend to work best, and training
has been most effective when disease-
specific materials were used. We have
found that ‘‘integrated booklets’’ and
‘‘integrated wall charts,’’ providing infor-
mation on transmission or control of more
than one NTD, tend to be too complex for
health educators and the target audience.
Few NTD programmes solely focus on
integrated PCT delivery, largely because:
(i) data to target interventions are often
incomplete [17–21], making it necessary
to undertake surveys, and (ii) complemen-
tary approaches, such as morbidity con-
trol, need to be scaled up simultaneously.
In Nigeria and Southern Sudan, where
more than one of the target diseases
needed to be mapped, combined NTD
surveys have been implemented [22,23].
While this approach is efficient at classify-
ing implementation units for LF, STH,
and schistosomiasis interventions, it can-
not be readily combined with the more
complex population-based prevalence sur-
veys for trachoma. However, integration
of trachoma rapid assessments into above
surveys could be envisaged [24]. Recent
work from Nigeria also indicates that
integration of trachoma into school-based
surveys for schistosomiasis can identify
trachoma hotspots in hypoendemic areas
where school attendance is high, thus
complementing population-based tracho-
ma prevalence surveys [25].
For PCT delivery, ivermectin can be
safely administered at the same time as
albendazole, while praziquantel can be
added only after at least one separate
treatment round. Combining these drugs
with azithromycin for trachoma control is
currently not recommended [5]. In prac-
tice this means that increased efficiency
over stand-alone PCT delivery can be
immediately realized in areas endemic for
onchocerciasis, LF, and STH, or for STH
and schistosomiasis, and in communities
that have previously received ivermectin
or praziquantel. Otherwise, separate treat-
ment rounds need to be organized and
budgeted for.
The need for data and associated
opportunities to integrate surveys, the
possibilities to readily target communities
with multiple PCT regiments, and the
gaps in complementary interventions
needed to ensure comprehensive disease
control, all need to be scrutinized during
strategy development. The decision on
what and where to integrate should then
be based on evidence not intuition, with
new materials and guidelines being piloted
before large-scale application.
How should integrated MDA be
delivered?
Whilst WHO provides technical guid-
ance on PCT co-administration [5], oper-
ational experience is limited. The experi-
ence that exists demonstrates that a range
of delivery channels can been used singly
Box 2. Definition of Monitoring and Evaluation
Monitoring is an ongoing process. The purpose of monitoring is to assess
whether programme activities are on track and whether changes are taking place.
Monitoring can be continuous or periodic. The most important aspect of
monitoring is to analyse data soon after they have been collected and to use the
findings to modify activities as necessary.
Evaluation is an overview of a programme up to a certain point in time. The
purpose of evaluation is to assess whether the activities are achieving or have
achieved the desired outputs and whether these outputs are likely to achieve or
have achieved the desired outcome (Figure 2). Evaluations are sometimes carried
out during programme implementation and should certainly be conducted at the
end. Mid-term evaluation can help to identify problems that may prevent the
programme achieving the desired outcome, so that appropriate changes can be
made to activities and outputs. End-of-programme evaluations can assess overall
success and summarize the lessons learned.
Box 1. Questions to Guide Strategy Development
Question 1: Are data on the presence and prevalence of the targeted NTDs
available for the whole country?
If yes go to question 2; if not, then one of the objectives should be:
Objective: To develop a comprehensive map of the geographical distribution of
NTDs targeted through an integrated control approach by (specify
month and year)
Question 2: What delivery systems are in place? (e.g., campaigns, networks of
community health workers, schools, or health facilities)
& What is their geographic coverage?
& What activities are they conducting and how often?
& What are their strengths and weaknesses? (i.e., what support
would be needed to deliver additional activities to avoid
undermining the existing efficiency)
Question 3: Which of these existing delivery systems would be best suited to:
& Sensitize communities and mobilize them to participate in
control activities?
& Conduct health education?
& Train community health workers and other cadres of health
workers?
& Supply drugs to the periphery and pre-position them?
& Distribute drugs to all eligible individuals on a regular basis?
& Deliver other components of a comprehensive control strategy,
such as surgery?
& Monitor and evaluate: (i) treatment coverage, (ii) adverse drug
events, (iii) impact on prevalence, intensity and morbidity,
and (iv) costs?
Depending on the answers to these questions one or more objectives
to scale up interventions should be formulated. For example:
Objective: To increase coverage (geographical and/or population) with (specify
intervention, e.g. PCT, surgery, access to clean water)t o( specify target,
e.g. 80%)b y( specify month and year)
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not be limited to PCT [30,31]. There is
therefore no ‘‘favourite’’ delivery channel,
nor should programme managers look for
synergies only within the NTDs. Other
control programmes, for example for
malaria, tuberculosis, or HIV/AIDS,
may in fact be better resourced and have
a wider geographical coverage than exist-
ing NTD programmes, potentially provid-
ing a stronger platform for co-implemen-
tation [32]. In practice this may mean that
delivery of albendazole plus ivermectin for
LF elimination is best combined with
other interventions that target large geo-
graphical areas, such as distribution of
long-lasting insecticidal nets [33]. Al-
though pockets within the same area
may be endemic for schistosomiasis, it
may be more efficient to integrate prazi-
quantel delivery into school-health pro-
grammes, to better target this more
expensive drug and minimize its associated
side effects [34].
Figure 3. Training, implementation and reporting flow for NTDs integrated into Uganda’s health system, including an alternative
approach often used by NGOs (see white arrows). The training cascade is initiated by existing MoH staff at a central level, referred to as the
national technical team. This team trains district trainers from subcounty or health subdistricts. These trainers then return to their duty stationst o
organize and coordinate training in their geographical areas. Within each area, parish supervisors and peripheral health centre staff are trained first,
after which these proceed to train teachers and community volunteers. Data retrieval and reporting follows similar channels. Reports collated at the
community level are delivered by parish supervisors to health centres. These data are then collected and collated by subcounty/health subdistrict
coordinators into a report for the health subdistrict and submitted to the district health officer. District health officers use these reports to write a
summary district report that is submitted to the NTD Secretariat in Kampala. The secretariat reports to the Director General of Health Services,
distributes copies of the report to partners, and submits the data to the national data bank. The same system and staff are use to report on other
community-based activities, such as TB, leprosy, malaria, and HIV programmes.
doi:10.1371/journal.pntd.0000755.g003
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feasible it is important to consult the target
communities, as they have valuable insight
into health care delivery in their own
settings and how it could be improved or
undermined. The success of existing NTD
programmes, such as community-directed
treatment with ivermectin (CDTI) for
onchocerciasis control, heavily depends
on community structures, customs, beliefs,
and values that make programme volun-
teers proud and motivated [35,36]. Mod-
ified or new delivery channels will need to
recognize and build upon these factors,
establishing and maintaining dialogue with
communities [37].
What should be monitored and
evaluated, and how?
Integration aims to increase efficiency
over stand-alone programmes. However,
there is little empirical evidence to show
whether and how such efficiency is
achieved. Monitoring of process and
evaluation of outcomes are therefore
important (Box 2). From the international
viewpoint, the evidence base for integrated
NTD control needs to be strengthened to
generate further financial support. From
the country perspective, information is
required to assess the success of the
strategic plan and modify activities when
these fail to achieve specified outputs
(Figure 2). Acquiring the necessary data
is challenging, partly because the target
diseases each have their own goals,
indicators, and methods [8], but also
because existing funding is largely targeted
at intervention delivery, rather than in-
depth monitoring and evaluation.
At present, most integrated NTD control
programmes largely focus on measuring
treatment coverage. However, if pro-
gramme success is judged only on the
number of people treated and the number
of different drugs given, then over-treat-
ment would make it look highly ‘‘success-
ful’’ although it would actually not be cost-
effective in terms of improving health. We
therefore encourage development and use
of additional indicators, such as parasite
prevalence, intensity of infection, and
morbidity indicators, so as to measure
programme performance. Ideally this and
other indicators should be incorporated
into an integrated monitoring and evalua-
tion platform, which could also include
collectionofcost data.Compilation of these
additional data will ultimately allow pro-
grammes to estimate cost-effectiveness, a
prerequisite for comparison of integrated
NTD control with stand-alone approaches.
For LF it is already an essential
programme requirement to establish sen-
tinel sites to monitor microfilarial preva-
lence and other morbidity and entomo-
logical indicators during the elimination
process [38]. Such sites are likely to be too
few and far between to generate sufficient-
ly detailed data to monitor the other
NTDs covered here, but data collected at
these sites could potentially contribute to a
picture of overall disease trends.
WHO provides disease-specific report-
ing formats and is developing guidelines
on monitoring and evaluation for integrat-
ed NTD control programmes. Specific
guidance on how to evaluate the epidemi-
ological impact of national helminth
control programmes has been provided
elsewhere [39] and additional tools have
been developed by the NTD Initiative
(www.neglecteddiseases.gov/resources/tools
_guidelines/index.html) led by the U.S.
Agency for International Development.
The NTD Secretariat could use these
resources to develop simple standardised
reporting forms to record coverage data
and to design surveys that specifically
measure outcome and impact. To avoid
establishment of a separate system,
reporting forms and procedures should
be consistent with routine MoH opera-
tions. The example of Uganda’s routine
system is provided in Figure 3.
What are the challenges?
Effective NTD control requires multi-
pronged strategies including treatment,
health education, provision of clean water
and sanitation, and surgery. Activities
other than PCT are often more costly
and difficult to scale up, making donors
less inclined to invest in them [40,41].
Countries wishing to embark on integrated
NTD control thus face the challenge of
implementing a comprehensive control
strategy in an environment where most
external resources are focused on only one
component—integrated PCT delivery.
This focus is the result of substantial global
advocacy on the potential benefits of PCT
integration, which has been extremely
successful at raising the NTD profile in
general. As a result, however, integration
of PCT delivery seems to have been
transformed from an activity into a key
objective. Programme managers may thus
be tempted or pressured to pursue this
‘‘objective,’’ rather than to balance inte-
grated and disease-specific approaches in
the interest of efficiency [15].
At the implementation level, integration
inevitably puts an additional strain on
existing systems. This may have no effect
on quality where there is spare capacity.
For systems already struggling to meet
their targets, however, integration can be
detrimental. For example, community
volunteers may feel overburdened by the
delivery of additional drugs, leading to
considerable attrition if demands for
payment or additional staff are not met
[42–44]. A major implementation chal-
lenge is therefore to find the optimal
balance between available inputs and
well-defined and achievable outputs of
delivery systems for NTD control.
Box 3. Key Learning Points
N Integration of NTD control programmes should be led by government
(e.g., an NTD Secretariat), to ensure that the approach is consistent with overall
health systems development and does not lead to the establishment of stand-
alone programmes.
N Clear structures for coordination, implementation, and reporting from
centre to periphery should be developed by the NTD Secretariat with input
from implementing partners, clarifying who is responsible for what. Formation
of NTD coordination mechanisms (e.g., task force) at central and district levels is
essential to support implementation.
N A comprehensive national strategy should be developed at the outset,
clearly outlining the goal, outcome, objectives, and activities of the integrated
NTD control programme over a specified timeframe of 3–5 years. The strategy
should provide information on structures to be used for coordination and
implementation, and the indicators used to monitor progress and outcomes.
N WHO recommends comprehensive strategies for the control of each NTD
targeted by an integrated approach. Although each of these strategies includes
PCT, other approaches to prevention and case-management are
equally important and should be supported.
N Coverage data should not be the only indicator to monitor integrated
NTD control programmes and to judge their success, particularly as these data
provide an incentive to distribute large quantities of drugs regardless of actual
need.
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avoided or overcome?
Successful establishment and running of
an integrated NTD control programme
hinges on effective partnership and imple-
mentation of a stepwise and evidence-
based approach, allowing many of the
immediate challenges to be minimized or
avoided. More specifically, forging close
in-country partnerships with relevant min-
istries and international agencies will
increase technical and material pro-
gramme contributions. Such coordination
and collaboration between sectors and
partners may, for example, allow targeting
of activities on education, water develop-
ment, and eye care to areas where PCT
delivery is ongoing or planned, hence
allowing implementation of the full SAFE
strategy for trachoma control [45]. Pool-
ing of resources for service delivery should
also increase the programme’s ability to
support delivery structures in terms of
community consultation, recruitment, and
adequate training of additional volunteers
to decrease the workload of the individual,
thus minimizing attrition.
Clearly there are key lessons to be
learned from the last 5 years of scaling
up integrated NTD control (Box 3). With
the anticipated vast increase in financial
support for NTD control from the US
government in 2011 (http://www.state.
gov/documents/organization/135888.pdf),
it will be crucial that these lessons be
applied to future programming; amongst
other improvements this would ensure
that ‘‘integration’’ reverts to the status of
an activity aimed at maximising efficien-
cy rather than being seen as an end in
itself.
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